Erratum: Combined inhibition of NEDD8-activating enzyme and mTOR suppresses NF2 loss–driven tumorigenesis (Molecular Cancer Therapeutics (2017) 16 (1693–1704) DOI: 10.1158/1535-7163.MCT-16-0821)

Jonathan Cooper, Qingwen Xu, Lu Zhou, Milica Pavlovic, Virginia Ojeda, Kamalika Moulick, Elisa de Stanchina, John T. Poirier, Marjorie Zauderer, Charles M. Rudin, Matthias A. Karajannis, C. Oliver Hanemann, Filippo G. Giancotti

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original version of this article (1), the CYR61 Western blot on the left-hand side of Fig. 2C was accidentally duplicated to the right-hand portion of the figure panel. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish (US)
Pages (from-to)450
Number of pages1
JournalMolecular cancer therapeutics
Volume20
Issue number2
DOIs
StatePublished - Feb 1 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum: Combined inhibition of NEDD8-activating enzyme and mTOR suppresses NF2 loss–driven tumorigenesis (Molecular Cancer Therapeutics (2017) 16 (1693–1704) DOI: 10.1158/1535-7163.MCT-16-0821)'. Together they form a unique fingerprint.

Cite this